Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Dihydroetorphine

From Wikipedia, the free encyclopedia
Opioid analgesic drug
Pharmaceutical compound
Dihydroetorphine
Clinical data
ATC code
  • none
Legal status
Legal status
Identifiers
  • (5R,6R,7R,9R,13S,14R)-7-[(R)-2-Hydroxypentan-2-yl] -6-methoxy-17-methyl-4,5-epoxy-6,14-ethanomorphinan-3-ol
CAS Number
PubChemCID
DrugBank
ChemSpider
UNII
KEGG
CompTox Dashboard(EPA)
ECHA InfoCard100.214.784Edit this at Wikidata
Chemical and physical data
FormulaC25H35NO4
Molar mass413.558 g·mol−1
3D model (JSmol)
  • Oc6ccc4c1c6O[C@H]3[C@]5(OC)[C@H](C[C@@]2([C@H](N(CC[C@@]123)C)C4)CC5)[C@@](O)(C)CCC
  • InChI=1S/C25H35NO4/c1-5-8-22(2,28)17-14-23-9-10-25(17,29-4)21-24(23)11-12-26(3)18(23)13-15-6-7-16(27)20(30-21)19(15)24/h6-7,17-18,21,27-28H,5,8-14H2,1-4H3/t17-,18-,21-,22-,23-,24+,25-/m1/s1 checkY
  • Key:BRTSNYPDACNMIP-FAWZKKEFSA-N checkY
  (verify)

Dihydroetorphine was developed by K. W. Bentley at McFarlan-Smith in the 1960s[1] and is a potentopioidanalgesic[2] used mainly in China. It is aderivative of the better-known opioidetorphine, a very potent veterinary painkiller andanesthetic medication used primarily for the sedation of large animals such as elephants, giraffes, and rhinos.

Dihydroetorphine is a semi-syntheticopioid used mainly as a strongpainkiller for humans.[3] It is several thousand times stronger thanmorphine (between 1000× and 12000× more potent depending what method is used for comparison),[1] although it is poorly absorbed when taken orally.Sublingual forms of dihydroetorphine are used in China at doses ranging from 20 to 40 μg repeated every 3–4 hours, and are reported to cause strong analgesia and relatively mild side effects compared to other opioids, although all the usual opioid side effects such asdizziness,sedation,nausea,constipation, andrespiratory depression can occur.Transdermal patches of dihydroetorphine have also been developed.[4]

Dihydroetorphine is considered to be somewhat lessaddictive than many other opioids, and it is also sometimes used in China as a substitute maintenance drug for opioid addicts,[5] in a similar fashion to how the related drugbuprenorphine is used in western nations.[6][7] It is presumably controlled as an "ester, ether, [or] salt" ofetorphine in the United States under the Controlled Substances Act 1970, and/or its pieces of the morphine carbon skeleton put it under the "morphine rule" thereof and/or the 1986 analogues act; it does not have its ownACSCN.[8] Regulation elsewhere may vary but would likely be similar to that for other strong opioid agonists.

Dihydroetorphine is illegal in Italy, as are its parent compoundsetorphine andacetorphine.[9]

See also

[edit]

References

[edit]
  1. ^abBentley KW, Hardy DG (June 1967). "Novel analgesics and molecular rearrangements in the morphine-thebaine group. 3. Alcohols of the 6,14-endo-ethenotetrahydrooripavine series and derived analogs of N-allylnormorphine and -norcodeine".Journal of the American Chemical Society.89 (13):3281–92.Bibcode:1967JAChS..89.3281B.doi:10.1021/ja00989a032.PMID 6042764.
  2. ^Martin TJ, Hairston CT, Lutz PO, Harris LS, Porreca F (September 1998). "Anti-allodynic actions of intravenous opioids in the nerve injured rat: potential utility of heroin and dihydroetorphine against neuropathic pain".European Journal of Pharmacology.357 (1):25–32.doi:10.1016/S0014-2999(98)00531-7.PMID 9788770.
  3. ^Lewis JW, Husbands SM (2004). "The orvinols and related opioids--high affinity ligands with diverse efficacy profiles".Current Pharmaceutical Design.10 (7):717–32.doi:10.2174/1381612043453027.PMID 15032698.
  4. ^Ohmori S, Morimoto Y (2002)."Dihydroetorphine: a potent analgesic: pharmacology, toxicology, pharmacokinetics, and clinical effects".CNS Drug Reviews.8 (4):391–404.doi:10.1111/j.1527-3458.2002.tb00236.x.PMC 6741694.PMID 12481194.
  5. ^Bo-Yi Q (1996)."Advances in dihydroetorphine: From analgesia to detoxification".Drug Development Research.39 (2):131–134.doi:10.1002/(SICI)1098-2299(199610)39:2<131::AID-DDR3>3.0.CO;2-Q.S2CID 201878290. Archived fromthe original on 2013-05-25. Retrieved2017-09-09.
  6. ^Gerak LR, Gauthier CR, France CR (April 2003). "Discriminative stimulus and antinociceptive effects of dihydroetorphine in rhesus monkeys".Psychopharmacology.166 (4):351–9.doi:10.1007/s00213-002-1268-y.PMID 12601499.S2CID 23944183.
  7. ^Husbands SM, Lewis JW (March 2003). "Opioid ligands having delayed long-term antagonist activity: potential pharmacotherapies for opioid abuse".Mini Reviews in Medicinal Chemistry.3 (2):137–44.doi:10.2174/1389557033405395.PMID 12570846.
  8. ^"DEA Diversion Control Division". Archived fromthe original on 2016-03-02. Retrieved2016-02-27.
  9. ^Salute, Ministero della."Tabelle delle sostanze stupefacenti e psicotrope".www.salute.gov.it (in Italian). Retrieved2022-04-09.

External links

[edit]
Opioids
Opiates/opium
Semisynthetic
Synthetic
Paracetamol-type
NSAIDs
Propionates
Oxicams
Acetates
COX-2 inhibitors
Fenamates
Salicylates
Pyrazolones
Others
Cannabinoids
Ion channel
modulators
Calcium blockers
Sodium blockers
Potassium openers
Myorelaxants
Others
Drugs used in treatment ofdrug dependence (N07B)
Nicotine dependence
Alcohol dependence
Opioid dependence
Benzodiazepine dependence
μ-opioid
(MOR)
Agonists
(abridged;
full list)
Antagonists
δ-opioid
(DOR)
Agonists
Antagonists
κ-opioid
(KOR)
Agonists
Antagonists
Nociceptin
(NOP)
Agonists
Antagonists
Others


Stub icon

Thisanalgesic-related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Dihydroetorphine&oldid=1308416092"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp